Las Vegas, NV -- (SBWIRE) -- 12/05/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Camtek LTD. (NASDAQ:CAMT), BioTelemetry Inc (NASDAQ:BEAT), Generex Biotechnology Corporation (OTCMKTS:GNBT), Harris Interactive Inc. (NASDAQ:HPOL)
Camtek LTD. (NASDAQ:CAMT) managed to keep its gain at 2.18% on above-normal volume of 6.42M shares. The stock settled at $4.68 after floating in a range of $4.45 to $5.13. Its latest price has reached market capitalization of $140.61 million. Its 52-week range has been $1.31 to $6.43. Camtek Ltd. (Camtek) designs, develops, manufactures and markets automated solutions dedicated for enhancing production processes and yield for the semiconductor manufacturing and packaging and the printed circuit board (PCB) and integrated circuit (IC) substrate industries. Camtek also designs, develops, manufactures and markets automated optical inspection (AOI), systems and related products.
For How Long CAMT will fight for Profitability? Read This Trend Analysis report
BioTelemetry Inc (NASDAQ:BEAT) traded down on a volume of 5.58 million, higher than its standard daily volume. Shares have dropped-19.94% to $8.55. Over the last twelve months, the stock has gained 294.1% and faced a worst price of $2. ioTelemetry, Inc. (BioTelemetry), formerly CardioNet, Inc., provides cardiac monitoring services, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. The Company operates in three segments: patient services, product and research services. The patient services business segment’s principal focus is on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders, through its core Mobile Cardiac Outpatient Telemetry(MCOT), event and Holter services in a healthcare setting.
Has BEAT Found The Bottom And Ready To Gain Momentum? Find Out Here
Generex Biotechnology Corporation (OTCMKTS:GNBT) settled -4.62% lower at $0.0310 on above-normal volume of 4.80M shares during the last trading day. The stock has its 12-month high at $0.07 and 52-week low price was $0.02. It traded in a range of $0.03 to $0.04 during the last trading day. Generex Biotechnology Corporation is a Canada-based Company, which develops drug delivery systems and technologies for the treatment of diabetes. The Company has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity. Its buccal insulin spray product, Generex Oral-lyn is in Phase III clinical trials at several sites around the world.
Will GNBT Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Harris Interactive Inc. (NASDAQ:HPOL) showed no change on high volume, trading at a volume of 3.98M versus its average daily volume of 119,058.00 shares. At $2, the stock has attained market capitalization of 116.60 million. Harris Interactive Inc. is a professional services firm that provides market research and polling services which include ad-hoc and customized qualitative and quantitative research, service bureau research (conducted for other market research firms), and long-term tracking studies.
Can HPOL Show a Strong Recovery? Find out in This Research Report
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)